Abivax dazzled investors and analysts with positive data from a pair of Phase III induction trials assessing obefazimod in adults with moderately to severely active ulcerative colitis. The results ...

The FDA is investigating the death last month of an eight-year-old boy in Brazil who had received Sarepta Therapeutics’ Elevidys® (delandistrogene moxeparvovec-rokl)—though the company and its ...

David Baker’s Nobel Prize-winning lab has generated AI-designed proteins to enhance the immune system's ability to detect and ...

Collins joins GEN editors to talk about the state of genomics, multiomics, and NGS. He also discusses the 25th anniversary of ...

Brown led the innovation of breakthrough technologies and product development designed to enable the analysis of anything, by ...

Spatial proteomics continues to transform biomedical research in understanding disease progression and therapeutic response.

In this fireside chat, Thaysen discusses how life has changed from his role at Illumina and his vision for the future in ...

The partnership combines Bio Usawa's understanding of African healthcare markets with Servare’s biopharmaceutical development ...

With greater investment to improve the scalability and consistency of manufacturing, EV-based medicine is poised to shape ...

This week's episode covers news about Sarepta, babies born following mitochondrial transfer, and AI identifying therapy targets.

Highlights of the Sanner facility include a 60,500-sq-ft site equipped with GMP-certified cleanrooms (ISO class 7 & 8) and ...

AstraZeneca has increased its investment in U.S. operations more than 14-fold, committing $50 billion to a range of ...